Biocartis

Tel: +32 470 12 34 56
Email: [email protected]
Web: www.biocartis.com/en

With its revolutionary and proprietary Idylla™ Platform, Biocartis aspires to enable personalized medicine for patients worldwide through universal access to molecular testing, by making molecular testing actionable, easy, fast and suitable for any lab. The Idylla™ Platform is a fully automated sample-to-result, real-time PCR-based system that offers in-house molecular biomarker testing in only 3 hours, allowing fast and optimal treatment selection. Today, Biocartis offers tests supporting melanoma, colorectal, lung, breast, thyroid, brain and blood cancer.